99 related articles for article (PubMed ID: 25663197)
1. Analysis of cancer marker in tissues with Hadamard transform fluorescence spectral microscopic imaging.
Xu H; Chen C; He Y; Tang HW; Zhang ZL; Li Y; Pang DW
J Fluoresc; 2015 Mar; 25(2):397-402. PubMed ID: 25663197
[TBL] [Abstract][Full Text] [Related]
2. [The distribution analysis of the biomarkers on breast cancer tissues by Hadamard transform spectral microscopic imaging].
Xu H; Chen C; Liu CM; Peng J; Li Y; Zhang ZL; Tang HW
Guang Pu Xue Yu Guang Pu Fen Xi; 2009 Dec; 29(12):3216-9. PubMed ID: 20210135
[TBL] [Abstract][Full Text] [Related]
3. Hadamard transform spectral microscopy for single cell imaging using organic and quantum dot fluorescent probes.
Xu H; Peng J; Tang HW; Li Y; Wu QS; Zhang ZL; Zhou G; Chen C; Li Y
Analyst; 2009 Mar; 134(3):504-11. PubMed ID: 19238287
[TBL] [Abstract][Full Text] [Related]
4. In situ spectral imaging of marker proteins in gastric cancer with near-infrared and visible quantum dots probes.
He Y; Xu H; Chen C; Peng J; Tang H; Zhang Z; Li Y; Pang D
Talanta; 2011 Jul; 85(1):136-41. PubMed ID: 21645682
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the bioconjugation efficiency of different quantum dots as probes for immunostaining tumor-marker proteins.
Xu H; Chen C; Peng J; Tang HW; Liu CM; He Y; Chen ZZ; Li Y; Zhang ZL; Pang DW
Appl Spectrosc; 2010 Aug; 64(8):847-52. PubMed ID: 20719046
[TBL] [Abstract][Full Text] [Related]
6. Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features.
Ning SF; Li JL; Luo CP; Wei CH; Lu YK; Liu HZ; Wei WE; Zhang LT
Int J Clin Exp Pathol; 2014; 7(12):8740-7. PubMed ID: 25674240
[TBL] [Abstract][Full Text] [Related]
7. Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization.
Annaratone L; Simonetti M; Wernersson E; Marchiò C; Garnerone S; Scalzo MS; Bienko M; Chiarle R; Sapino A; Crosetto N
Oncotarget; 2017 Mar; 8(12):18680-18698. PubMed ID: 28423635
[TBL] [Abstract][Full Text] [Related]
8. Brief fixation enables same-day breast cancer diagnosis with reliable assessment of hormone receptors, E-cadherin and HER2/Neu.
Halilovic A; Bulte J; Jacobs Y; Braam H; van Cleef P; Schlooz-Vries M; Werner A; Boelens O; Nagtegaal I; de Wilt H; Bult P
J Clin Pathol; 2017 Sep; 70(9):781-786. PubMed ID: 28325747
[TBL] [Abstract][Full Text] [Related]
9. Comparison of quantum dots immunofluorescence histochemistry and conventional immunohistochemistry for the detection of caveolin-1 and PCNA in the lung cancer tissue microarray.
Chen H; Xue J; Zhang Y; Zhu X; Gao J; Yu B
J Mol Histol; 2009 Aug; 40(4):261-8. PubMed ID: 19908148
[TBL] [Abstract][Full Text] [Related]
10. An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer.
Wesseling J; Tinterri C; Sapino A; Zanconati F; Lutke-Holzik M; Nguyen B; Deck KB; Querzoli P; Perin T; Giardina C; Seitz G; Guinebretière JM; Barone J; Dekker L; de Snoo F; Stork-Sloots L; Roepman P; Watanabe T; Cusumano P
Virchows Arch; 2016 Sep; 469(3):297-304. PubMed ID: 27377889
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
[TBL] [Abstract][Full Text] [Related]
12. Application of multispectral imaging in quantitative immunohistochemistry study of breast cancer: a comparative study.
Liu WL; Wang LW; Chen JM; Yuan JP; Xiang QM; Yang GF; Qu AP; Liu J; Li Y
Tumour Biol; 2016 Apr; 37(4):5013-24. PubMed ID: 26537585
[TBL] [Abstract][Full Text] [Related]
13. Quantitative DNA imaging in breast tumor cells by a Hadamard transform fluorescence imaging microscope.
Tang HW; Luo MN; Li T; Pan L
Anal Sci; 2006 May; 22(5):701-7. PubMed ID: 16770048
[TBL] [Abstract][Full Text] [Related]
14. Quantum dots-based molecular classification of breast cancer by quantitative spectroanalysis of hormone receptors and HER2.
Chen C; Sun SR; Gong YP; Qi CB; Peng CW; Yang XQ; Liu SP; Peng J; Zhu S; Hu MB; Pang DW; Li Y
Biomaterials; 2011 Oct; 32(30):7592-9. PubMed ID: 21745686
[TBL] [Abstract][Full Text] [Related]
15. HER2 status in elderly women with breast cancer.
Laird-Fick HS; Gardiner JC; Tokala H; Patel P; Wei S; Dimitrov NV
J Geriatr Oncol; 2013 Oct; 4(4):362-7. PubMed ID: 24472480
[TBL] [Abstract][Full Text] [Related]
16. Allelic imbalance at the HER2/TOP2A locus in breast cancer.
Huijsmans CJ; van den Brule AJ; Rigter H; Poodt J; van der Linden JC; Savelkoul PH; Hilbink M; Hermans MH
Diagn Pathol; 2015 May; 10():56. PubMed ID: 26022247
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
[TBL] [Abstract][Full Text] [Related]
18. Small-Protein-Stabilized Semiconductor Nanoprobe for Targeted Imaging of Cancer Cells.
Zhao N; Liu S; Jiang Q; Lan T; Cheng Z; Liu H
Chembiochem; 2016 Jul; 17(13):1202-6. PubMed ID: 27123671
[TBL] [Abstract][Full Text] [Related]
19. Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics.
Liu X; Zheng Y; Qiao C; Qv F; Wang J; Ding B; Sun Y; Wang Y
Diagn Pathol; 2015 May; 10():50. PubMed ID: 25956130
[TBL] [Abstract][Full Text] [Related]
20. Automated measurement of multiple cancer biomarkers using quantum-dot-based microfluidic immunohistochemistry.
Kwon S; Cho CH; Lee ES; Park JK
Anal Chem; 2015 Apr; 87(8):4177-83. PubMed ID: 25826006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
